Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature

Anti-tumor necrosis factor (TNF) biologics are currently amongst the most widely used and efficacious therapies for inflammatory bowel disease (IBD). The development of therapeutic drug monitoring for infliximab and adalimumab has allowed for measurement of drug levels and antidrug antibodies. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothari, Mansi M, Nguyen, Douglas L, Parekh, Nimisha K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547373/
https://www.ncbi.nlm.nih.gov/pubmed/28828193
http://dx.doi.org/10.4292/wjgpt.v8.i3.155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547373/
https://www.ncbi.nlm.nih.gov/pubmed/28828193
http://dx.doi.org/10.4292/wjgpt.v8.i3.155

Ejemplares similares